New guidance has been issued to help nurses and GPs take on extra roles that will expand primary care services.The …
Pharmaceutical companies, researchers and academic virologists around the world have joined the race to identify and ultimately develop vaccines to …
Plans to offer GP practices a guaranteed minimum income have been launched to rescue the new general practice contract.The proposals …
$180bn Pfizer moves into a league of its ownThe newly enlarged Pfizer has begun life bullishly with a 10% growth …
GlaxoSmithKline and Bayer have agreed to pay $344 million to settle charges of defrauding the US Government healthcare system.The payout …
Primary care trusts in England are to work with US healthcare provider Kaiser Permanente on new ways to reduce hospital …
Abbott Laboratories has launched its new rheumatoid arthritis treatment Humira in Europe claiming its biggest ever product could eventually become …
Prexige, the new challenger to the established Cox-II drugs from Novartis has been dealt a serious blow after the FDA …
Fred Hassan has outlined his plans to turn round the fortunes of struggling Schering-Plough after being installed as the company's …
Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …
Novartis' atypical antipsychotic Clozaril could lead to a reduction in suicide rate among patients suffering from schizophrenia, according to a …
The UK patent system is damaging scientific research and creating a old rush mentality according to the Royal Society.The current …
The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …
GlaxoSmithKline has claimed victory in its controversial bid to block parallel imports of its drugs from Canada into the US.The …
Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …
The UK patent system is damaging scientific research and creating a "gold rush mentality", according to the Royal Society.The current …